1784 0 Kommentare BioCentury Launches the Third Decade of Future Leaders in the Biotech Industry - Seite 3

This premier Wall Street event is one of two annual U.S. investor conferences organized by BioCentury. The next Wall Street conference, the 21st Annual NewsMakers in the Biotech Industry, will take place in New York City on September 26, 2014, at the Millennium Broadway Hotel & Conference Center.

BioCentury also co-organizes BioEquity Europe, which will take place in Amsterdam, May 21 - 22, 2014. The 15th Annual BioEquity Europe will be the premier event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for business development and licensing professionals from pharmaceutical companies to assess top partnering and licensing prospects.

About BioCentury
Since 1993, BioCentury Publications, Inc. has provided essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, regulators, public policy makers and the scientific community. This audience has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, data products and collaborative industry conferences in the U.S., Europe and Asia.

BioCentury's titles include the flagship BioCentury®, the Bernstein Report on BioBusiness; its SciBX: Science-Business eXchange™ translational science partnership with Nature Publishing Group; and its BioCentury Extra™ online daily newspaper. These timely journals are backed by BCIQ: BioCentury Online Intelligence™, an online business intelligence resource. BioCentury also produces its BioCentury This Week biotech public affairs television program in partnership with the Gannett-owned WUSA9 CBS affiliate in Washington, D.C. The program is aired in Washington each Sunday, on selected Public Broadcasting System member stations and distributed globally online at www.biocenturytv.com.